Changes in the quality of life of early breast cancer patients and comparison with the normative Slovenian population
References
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–249. doi: 10.3322/caac.21660
- Institute of Oncology Ljubljana. Cancer registry. [Internet]. [cited 2023 Jan 22]. Available at: http://www.slora.si/en/stevilo-zivih-bolnikov
- Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–76. doi: 10.1093/jnci/85.5.365
- Michels FAS, Latorre MDRDDO, Maciel MDS. Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer. Rev Bras Epidemiol 2013; 16: 352–363. doi: 10.1590/S1415-790X2013000200011
- Giesinger JM, Kieffer JM, Fayers PM, Groenvold M, Petersen MA, Scott NW. EORTC Quality of Life Group Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol 2016; 69: 79–88. doi: 10.1016/j.jclinepi.2015.08.007
- Schmidt ME, Scherer S, Wiskemann J, Steindorf K. Return to work after breast cancer: the role of treatment-related side effects and potential impact on quality of life. Eur J Cancer Care 2019; 28: e13051. doi: 10.1111/ecc.13051
- von Ah D, Crouch A. Relationship of perceived everyday cognitive function and work engagement in breast cancer survivors. Support Care Cancer 2021; 29: 303–4309. doi: 10.1007/s00520-020-05950-8
- Arndt V, Merx H, Stürmer T, Stegmaier C, Ziegler H, Brenner H. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer 2004; 40: 673–80. doi: 10.1016/j.ejca.2003.12.007
- Ahn SH, Park BW, Noh DY, Nam SJ, Lee ES, Lee MK, et al. Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol 2007; 18: 173–82. doi: 10.1093/annonc/mdl333. Erratum in: Ann Oncol 2009; 20: 1753–4.
- Grašič Kuhar C, Gortnar Cepeda T, Kovač T, Kukar M, Ružić Gorenjec N. Mobile app for symptom management and associated quality of life during systemic treatment in early stage breast cancer: nonrandomized controlled prospective cohort study. JMIR Mhealth Uhealth 2020; 8: e17408. doi: 10.2196/17408
- Velenik V, Secerov-Ermenc A, But-Hadzic J, Zadnik V. Health-related quality of life assessed by the EORTC QLQ-C30 Questionnaire in the general Slovenian population. Radiol Oncol 2017; 51: 342–50. doi: 10.1515/raon-2017-0021
- Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, et al; ESMO Guidelines Working Group. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl 6): vi7–23. doi: 10.1093/annonc/mdt284
- Fayers P, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 scoring manual. 3rd edition. Brussels: EORTC Brussels; 2001. [Internet]. [cited 2020 Jun 22]. Available at: https://www.eortc.org/app/uploads/sites/2/2018/02/SCmanual.pdf
- Scoring of the QLQ-C30 Summary Score. [Internet]. [cited 2022 Nov 26]. Available at: https://qol.eortc.org/app/uploads/sites/2/2018/02/scoring_of_the_qlq-c30_summary_score.pdf
- Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139–44. doi: 10.1200/JCO.1998.16.1.139
- R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2020. [Internet]. [cited 2021 Jun 6]. Available at: https://www.R-project.org/
- Doege D, Thong MS, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, et al. Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany. Breast Cancer Res Treat 2019; 175: 499–510. doi: 10.1007/s10549-019-05188-x
- Ferreira AR, Di Meglio A, Pistilli B, Gbenou AS, El-Mouhebb M, Dauchy S, et al. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol 2019; 30: 1784–95. doi: 10.1093/annonc/mdz298
- Husson O, de Rooij BH, Kieffer J, Oerlemans S, Mols F, Aaronson NK, et al. The EORTC QLQ-C30 Summary Score as prognostic factor for survival of patients with cancer in the “real-world”: Results from the Population-Based PROFILES Registry. Oncologist 2020; 25: e722–e32. doi: 10.1634/theoncologist.2019-0348
- Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 2005; 23: 4945–53. doi: 10.1200/JCO.2005.03.475.
- Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M. It's not over when it's over: long-term symptoms in cancer survivors – a systematic review. Int J Psychiatry Med 2010; 40: 163–181. doi:10.2190/PM.40.2.c
- de Ligt KM, Heins M, Verloop J, Ezendam NPM, Smorenburg CH, Korevaar JC, et al. The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors. Breast Cancer Res Treat 2019; 178: 703–11. doi: 10.1007/s10549-019-05433-3
- van der Willik KD, Koppelmans V, Hauptmann M, Compter A, Ikram MA, Schagen SB. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study. Breast Cancer Res 2018; 20: 135. doi: 10.1186/s13058-018-1062-3
- Zehra S, Doyle F, Barry M, Walsh S, Kell MR. Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis. Breast Cancer 2020; 27: 534–66. doi: 10.1007/s12282-020-01076-1
- Yfantis A, Sarafis P, Moisoglou I, Tolia M, Intas G, Tiniakou I, et al. How breast cancer treatments affect the quality of life of women with non-metastatic breast cancer one year after surgical treatment: a cross-sectional study in Greece. BMC Surg 2020; 20: 210. doi: 10.1186/s12893-020-00871-z
- Yoon J, Malin JL, Tao ML, Tisnado DM, Adams JL, Timmer MJ, et al. Symptoms after breast cancer treatment: are they influenced by patient characteristics? Breast Cancer Res Treat 2008; 108: 153–165. doi: 10.1007/s10549-007-9599-3
- Joly F, Lange M, Dos Santos M, Vaz-Luis I, Di Meglio A. Long-term fatigue and cognitive disorders in breast cancer survivors. Cancers 2019; 11: 1896. doi: 10.3390/cancers11121896
- Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol 2019; 30: 1925–40. doi: 10.1093/annonc/mdz410
- National Comprehensive Cancer Networ. NCCN guidelines for supportive care. [Internet]. [cited 2021 Jun 6]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf
- Puetz TW, Herring MP. Differential effects of exercise on cancer-related fatigue during and following treatment: a meta-analysis. Am J Prev Med 2012; 43: e1–24. doi: 10.1016/j.amepre.2012.04.027
Language: English
Page range: 211 - 219
Submitted on: Nov 27, 2022
Accepted on: Dec 26, 2022
Published on: Jun 21, 2023
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2023 Cvetka Grasic Kuhar, Tjasa Gortnar Cepeda, Christian Kurzeder, Marcus Vetter, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.